GSK fol­lows Pfiz­er in meningo­coc­cal vac­cine race with new FDA nod

GSK has snagged FDA ap­proval for its 5-in-1 meningo­coc­cal vac­cine, pro­pelling it to a fa­mil­iar po­si­tion: ri­val­ing Pfiz­er.

Pen­men­vy was ap­proved Fri­day for chil­dren and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER